Atıf Formatları
Clinical Features and HSCT Outcome for SCID in Turkey
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

A. Ikinciogullari Et Al. , "Clinical Features and HSCT Outcome for SCID in Turkey," JOURNAL OF CLINICAL IMMUNOLOGY , vol.39, no.3, pp.316-323, 2019

Ikinciogullari, A. Et Al. 2019. Clinical Features and HSCT Outcome for SCID in Turkey. JOURNAL OF CLINICAL IMMUNOLOGY , vol.39, no.3 , 316-323.

Ikinciogullari, A., ÇAĞDAŞ AYVAZ, D. N., Dogu, F., Tugrul, T., Karasu, G., Haskologlu, S., ... AKSOYLAR, S.(2019). Clinical Features and HSCT Outcome for SCID in Turkey. JOURNAL OF CLINICAL IMMUNOLOGY , vol.39, no.3, 316-323.

Ikinciogullari, Aydan Et Al. "Clinical Features and HSCT Outcome for SCID in Turkey," JOURNAL OF CLINICAL IMMUNOLOGY , vol.39, no.3, 316-323, 2019

Ikinciogullari, Aydan Et Al. "Clinical Features and HSCT Outcome for SCID in Turkey." JOURNAL OF CLINICAL IMMUNOLOGY , vol.39, no.3, pp.316-323, 2019

Ikinciogullari, A. Et Al. (2019) . "Clinical Features and HSCT Outcome for SCID in Turkey." JOURNAL OF CLINICAL IMMUNOLOGY , vol.39, no.3, pp.316-323.

@article{article, author={Aydan Ikinciogullari Et Al. }, title={Clinical Features and HSCT Outcome for SCID in Turkey}, journal={JOURNAL OF CLINICAL IMMUNOLOGY}, year=2019, pages={316-323} }